Search

Your search keyword '"Agostoni C."' showing total 49 results
Start Over Author "Agostoni C." Publisher wiley
49 results on '"Agostoni C."'

9. Concentrations of dioxins and other organochlorines (PCBs, DDTs, HCHs) in human milk from Seveso, Milan and a Lombardian rural area in Italy: a study performed 25 years after the heavy dioxin exposure in Seveso

Author

Weiss, J, primary, Päpke, O, additional, Bignert, A, additional, Jensen, S, additional, Greyerz, E, additional, Agostoni, C, additional, Besana, R, additional, Riva, E, additional, Giovannini, M, additional, and Zetterström, R, additional

Published
2007
Full Text
View/download PDF

17. PC92 APPETITE CONTROL IN BREASTFED AND MILK FORMULA FED INFANTS

Author

Gruszfeld, D., primary, Janas, R., additional, Socha, J., additional, Koletzko, B., additional, Broekaert, I., additional, Brasseur, D., additional, Sengier, A., additional, Giovannini, M., additional, Agostoni, C., additional, Monasterolo, R. Closa, additional, and Luque, V., additional

Published
2004
Full Text
View/download PDF

48. Nutritional issues in treating phenylketonuria.

Author

Feillet F and Agostoni C

Subjects
Animals, Breast Feeding, Diet, Vegetarian, Dietary Supplements, Fatty Acids, Unsaturated physiology, Fatty Acids, Unsaturated therapeutic use, Food, Formulated, Humans, Milk, Human chemistry, Milk, Human physiology, Phenylketonurias complications, Nutritional Physiological Phenomena, Phenylketonurias diet therapy
Abstract

A phenylalanine (Phe)-restricted diet is the mainstay of phenylketonuria (PKU) treatment, and, in recent years, the nutritional management of PKU has become more complex in order to optimize patients' growth, development and diet compliance. Dietary restriction of Phe creates a diet similar to a vegan diet, and many of the nutritional concerns and questions applicable to vegans who wish to avoid animal products are also relevant to patients with PKU. Owing to their nutritional characteristics, breast milk and breastfeeding should be given greater consideration as a useful food in patients with PKU and in those with other inborn errors of metabolism. Further key issues for consideration include the quality of the available amino acid substitutes, the neurotrophic and neuroprotective effects of added long-chain polyunsaturated fatty acids (e.g. docosahexaenoic acid), micronutrient deficiencies, bone disease and antioxidant status. Long-term dietary guidance and monitoring of the nutritional status of patients with PKU should be part of a follow-up programme that continues for life.

Published
2010
Full Text
View/download PDF

49. Lipid status and fatty acid metabolism in phenylketonuria.

Author

Giovannini M, Biasucci G, Agostoni C, Luotti D, and Riva E

Subjects
Adolescent, Child, Child, Preschool, Fatty Acids blood, Humans, Infant, Infant, Newborn, Lipids blood, Phenylketonurias blood, Fatty Acids metabolism, Lipid Metabolism, Phenylketonurias metabolism
Abstract

Owing to dietary treatment, patients with phenylketonuria (PKU) are supplied with only small amounts of animal fats and show low blood cholesterol levels and a poor long-chain polyunsaturated fatty acid (LC-PUFA) status. Endogenous synthesis should compensate for the physiological need for cholesterol for growth, but supplementary exogenous LC-PUFA seems advisable. PKU infants could develop depletion of docosahexaenoic acid, fundamental for the functional development of the central nervous system. The availability of arachidonic acid from plasma in PKU has been found to be related to dietary compliance, and seems to influence the synthesis of arachidonate-derived eicosanoids. Trials of dietary supplementation of PKU patients with oils containing LC-PUFA are in progress, but the functional consequences of these supplementations need further investigation.

Published
1995
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results